Date & Time
Location
Auditorium
Fox Chase Cancer Center
Registration Information
$15 for general registration
Includes breakfast, lunch, coffee breaks and registration materials
Complimentary registration
for presenters, residents, fellows,
and for medical staff members, fellows, residents and other health-care providers of Temple Health
The Atlantic Regional Hematopathology Meeting
Brochure [PDF]
PRESENTED BY
Fox Chase Cancer Center and
The Temple Health Office for Continuing Medical Education
FEATURED SPEAKERS
Richard I. Fisher, MD
President and CEO, Cancer Center Director, The Robert C. Young, MD,
Chair in Cancer Research, Fox Chase Cancer Center; Senior Associate Dean, Lewis Katz School of Medicine, Temple University
Keynote Address: “Targeted Therapy for Diffuse Large B-Cell Lymphoma”
Roland Schwarting, MD
Chairman and Chief, Department of Pathology, Cooper University Health Care
“Behind the Scenes of Science: A Personal Experience”
COURSE DIRECTOR
Tahseen I. Al-Saleem, MD
Professor, Department of Pathology, Fox Chase Cancer Center
COURSE CO-DIRECTORS
Essel Dulaimi Al-Saleem, MD
Assistant Professor, Department of Pathology; Director, Outpatient
Laboratory; Director of Hematopathology and Flow Cytometry (Interim),
Fox Chase Cancer Center
Henry C. Fung, MD, FACP, FRCP
Vice-Chair, Hematology Program, Department of Hematology/Oncology,
Fox Chase Cancer Center; Director, Fox Chase-Temple BMT Program
ACCREDITATION STATEMENT
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.
CERTIFICATION STATEMENT
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 5.0 AMA
PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.
DISCLOSURE POLICY
It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias, and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest pertaining to the content of the activity and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
Inquiries: LUCÍA TONO-RAMÍREZ, PHD, JD, MED | 215-728-3797 | [email protected]